Serum Institute resumes COVID-19 vaccine exports
PTI, Nov 26, 2021, 6:29 PM IST
Serum Institute of India — the world’s largest vaccine maker — on Friday said it has resumed exports of Covishield vaccine to low- and middle-income countries with the first batch of consignment leaving its Pune facility.
The vaccine maker has cumulatively produced 1.25 billion doses so far, a company statement said.
”The first batches of its COVISHIELD COVID-19 vaccine left the SII manufacturing facility in Pune earlier today, for distribution to low- and middle-income countries via the COVAX mechanism,” it said. ”SII’s supply of doses via COVAX is expected to increase substantially into Quarter 1 2022,” it added.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
No one has right to break law: BJP on Sambhal violence
Will review INDI alliance’s dismal performance in Maharashtra, says Tejashwi Yadav
Minor girl out with friend raped in MP forest; truck driver, associate held
Kangana says MVA lost in Maharashtra because it disrespected women
UP: Protest over Sambhal mosque survey turns violent; 3 killed, 20 cops among injured
MUST WATCH
Latest Additions
No one has right to break law: BJP on Sambhal violence
Ullal: Auto-rickshaw accident near Konaje claims driver’s life
Congress victory in bypolls not a clean chit to CM in MUDA case: R Ashoka
IPL 2025 | Got someone who can do captaincy job: Ricky Ponting on Shreyas Iyer
Will review INDI alliance’s dismal performance in Maharashtra, says Tejashwi Yadav
Thanks for visiting Udayavani
You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.